Testosterone Replacement Therapy and Cardiovascular Events
نویسندگان
چکیده
منابع مشابه
Testosterone therapy, thrombosis, thrombophilia, cardiovascular events.
There are similar time intervals between starting testosterone therapy (TT) and development of thrombotic (~4.5 months) or cardiovascular (CVD) events (~3 months) which may, speculatively, reflect a shared pathophysiology. We have described thrombotic events 5 months (median) after starting TT in 38 men and 4 women, including 27 with deep venous thrombosis-pulmonary embolism, 12 with osteonecro...
متن کاملTrials of testosterone replacement reporting cardiovascular adverse events
The numbers of testosterone prescriptions written have increased several-fold worldwide, but the incidence of pathological hypogonadism due to hypothalamic, pituitary, and testicular disease has remained unchanged. Most of these prescriptions are being dispensed to middle-aged and older men who have experienced age-related decline in serum testosterone levels; a subset of the population in whic...
متن کاملCorrigendum: Testosterone Replacement Therapy and Cardiovascular Risk: A Review
Recent reports in the scientific and lay press have suggested that testosterone (T) replacement therapy (TRT) is likely to increase cardiovascular (CV) risk. In a final report released in 2015, the Food and Drug Administration (FDA) cautioned that prescribing T products is approved only for men who have low T levels due to primary or secondary hypogonadism resulting from problems within the tes...
متن کاملCardiovascular Benefits of Testosterone Replacement Therapy in the Andropausal Male
Androgen deficiency has been receiving a lot of attention as an evolving health concern in the industrialized world. With population aging, hypogonadism has become a challenging medical problem confronting practicing physicians. The importance of this increasingly prevalent disease arises from its potentially debilitating and serious consequences, such as atherosclerosis, diabetes mellitus, met...
متن کاملWhich testosterone replacement therapy?
Three different forms of testosterone (T) replacement therapy were compared; they were the intramuscular injection of mixed testosterone esters 250 mg; the subcutaneous implantation of 6 X 100 mg pellets of fused testosterone; and the oral administration of testosterone undecanoate (TU) 80 mg twice daily. Six hypogonadal males were treated with oral TU for an eight week period, during which tim...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
سال: 2017
ISSN: 1016-5169
DOI: 10.5543/tkda.2017.00531